OBIO
Orchestra BioMed Holdings, Inc.Company Information
- Company Name
- Orchestra BioMed Holdings, Inc.
- CIK
- CIK0001814114
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- OBIO: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- OBIO
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-09-03
- Last sale
- 2026-09-01
- Shares purchased (TTM)
- 67,636
- Shares sold (TTM)
- 60,032
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 27,913,147
- Shares outstanding
- 63,812,098
- Ownership
- 43.74%
Earnings Market Reaction
- Filing date
- 2026-08-10
- Price on filing date
- —
- 1-month reaction
- 13.90%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 20 | 28 | 35 | 42 | 19 | 18 | 22 | 26 | 24 | 23 | 31 | 19 | ||||||
| Marketable Securities Current | 89 | 66 | 72 | 54 | 15 | 32 | 45 | 41 | 41 | 52 | 57 | 89 | ||||||
| Other Short Term Investments | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets Current | 111 | 96 | 108 | 98 | 36 | 52 | 69 | 69 | 66 | 76 | 89 | 110 | ||||||
| Property Plant And Equipment Net | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | ||||||
| Other Investments | - | - | - | - | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Equity Securities Without Readily Determinable Fair Value Amount | - | - | 2 | 2 | 2 | - | 2 | - | - | - | - | - | ||||||
| Assets | 116 | 101 | 115 | 105 | 43 | 59 | 76 | 75 | 72 | 83 | 95 | 116 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 6 | 6 | 6 | 8 | 5 | 6 | 5 | 5 | 6 | 3 | 3 | 3 | ||||||
| Accrued Liabilities Current | 7 | 7 | 10 | 7 | 7 | 5 | 6 | 7 | 4 | 4 | 5 | 4 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | ||||||
| Deferred Revenue Current | - | - | - | 5 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 4 | ||||||
| Loans Payable Current | - | - | - | - | - | - | - | - | - | - | - | 10 | ||||||
| Liabilities Current | 13 | 14 | 17 | 21 | 17 | 15 | 16 | 16 | 15 | 10 | 11 | 21 | ||||||
| Deferred Revenue Noncurrent | - | - | - | 9 | 10 | 11 | 11 | 11 | 13 | 14 | 15 | 14 | ||||||
| Convertible Long Term Notes Payable | 20 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Long Term Loans Payable | 14 | 14 | 14 | 14 | 14 | 14 | 14 | - | - | - | - | - | ||||||
| Embedded Derivative Fair Value Of Embedded Derivative Liability | 2 | 3 | 3 | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | 0 | ||||||
| Liabilities | 86 | 50 | 51 | 61 | 43 | 42 | 43 | 29 | 28 | 25 | 27 | 37 | ||||||
| Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | 10 | 10 | 10 | - | - | - | - | - | - | - | - | - | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 426 | 424 | 416 | 413 | 348 | 345 | 343 | 340 | 322 | 320 | 317 | 316 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -407 | -383 | -363 | -369 | -348 | -329 | -310 | -294 | -278 | -262 | -249 | -236 | ||||||
| Stockholders Equity | 19 | 41 | 54 | 44 | 0 | 17 | 33 | 46 | 44 | 57 | 68 | 80 | ||||||
| Liabilities And Stockholders Equity | 116 | 101 | 115 | 105 | 43 | 59 | 76 | 75 | 72 | 83 | 95 | 116 | ||||||
| Temporary Equity Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | - | - | - | 0.00 | - | - | - | - | - | ||||||
| Preferred Stock Shares Outstanding | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Temporary Equity Shares Issued | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Temporary Equity Shares Outstanding | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Temporary Equity Liquidation Preference | 20 | 20 | 20 | - | - | - | - | - | - | - | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 340 | 340 | 340 | 340 | 340 | 340 | 340 | 340 | 340 | 340 | 340 | 340 | ||||||
| Common Stock Shares Issued | 60 | 59 | 57 | 56 | 39 | 38 | 38 | 38 | 36 | 36 | 36 | 36 | ||||||
| Shares Outstanding | 60 | 59 | 57 | 56 | 39 | 38 | 38 | 38 | 36 | 36 | 36 | 36 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialOrchestra BioMed Holdings, Inc. (OBIO) — SEC Financial Statements & Analysis
Orchestra BioMed Holdings, Inc. (OBIO) is a surgical & medical instruments & apparatus company, incorporated in DE. Orchestra BioMed Holdings, Inc. trades on Nasdaq as: OBIO. Orchestra BioMed Holdings, Inc. (OBIO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10. Based on that filing, Orchestra BioMed Holdings, Inc. carries a market cap of $275.35M, a P/E ratio of -4.64x, a P/B ratio of 14.25x, a P/S ratio of 8.61x, an enterprise value of $275.32M, and an EV/EBITDA multiple of -4.78x. On profitability, it posts a gross margin of 99.51%, an operating margin of -181.36%, a net margin of -185.51%, a Return on Equity (ROE) of -604.73%, a Return on Assets (ROA) of -74.84%, and a Return on Invested Capital (ROIC) of -7544.04%. Per share, it reports EPS of $-0.93, diluted EPS of $-0.93, free cash flow per share of $-0.93, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 986.14% year-over-year, net income growth of -14.89% year-over-year, and EPS growth of -48.80% year-over-year. On the balance sheet, it maintains a current ratio of 8.26x, a quick ratio of 8.17x, working capital of $97.77M, a debt-to-equity ratio of 4.47x, a debt ratio of 0.75, an interest coverage ratio of -15.00x, free cash flow of $-59.10M (TTM), and net debt of $-30.00K. Figures sourced from SEC EDGAR.
- Market Cap
- $275.35M
- P/E TTM
- -4.64x
- EPS TTM
- $-0.93
- P/B TTM
- 14.25x
- ROE TTM
- -604.73%
- ROA TTM
- -74.84%
- Debt To Equity
- 4.47x
- Free Cash Flow TTM
- $-59.10M
- Net Revenue TTM Growth 1Y
- 986.14%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Orchestra BioMed Holdings, Inc. in?
Orchestra BioMed Holdings, Inc. (OBIO) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does OBIO trade on?
Orchestra BioMed Holdings, Inc. (OBIO) trades on the Nasdaq.
Where is Orchestra BioMed Holdings, Inc. incorporated?
Orchestra BioMed Holdings, Inc. is incorporated in DE.
When was Orchestra BioMed Holdings, Inc. (OBIO)'s most recent SEC filing?
Orchestra BioMed Holdings, Inc. (OBIO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10.
What is OBIO's market cap?
Orchestra BioMed Holdings, Inc. (OBIO) has a market capitalization of $275.35M as of 2026-06-30.
What is OBIO's EPS (earnings per share)?
Orchestra BioMed Holdings, Inc. (OBIO)'s trailing twelve month EPS is $-0.93 as of 2026-06-30.
What is OBIO's ROE (return on equity)?
Orchestra BioMed Holdings, Inc. (OBIO)'s trailing twelve month Return on Equity (ROE) is -604.73% as of 2026-06-30.
What is OBIO's ROA (return on assets)?
Orchestra BioMed Holdings, Inc. (OBIO)'s trailing twelve month Return on Assets (ROA) is -74.84% as of 2026-06-30.
What is OBIO's ROIC (return on invested capital)?
Orchestra BioMed Holdings, Inc. (OBIO)'s trailing twelve month Return on Invested Capital (ROIC) is -7544.04% as of 2026-06-30.
What is OBIO's EV/EBITDA?
Orchestra BioMed Holdings, Inc. (OBIO)'s trailing twelve month EV/EBITDA is -4.78x as of 2026-06-30.